| 5-FU | 5-fluorouracil |
| ADCC | antibody-dependent cellular cytotoxicity |
| AKT | protein kinase B |
| ATM | mutated in the disease ataxia telangiectasia |
| ATP | adenosine triphosphate |
| Apo2L | Apo-2 ligand |
| Bak | Bcl-2 antagonist or killer |
| Bax | Bcl-2-associated X protein |
| Bcl-2 | B-cell CLL/lymphoma 2 |
| Bcl-XL | B-cell lymphoma-extra-large |
| BH3 | Bcl-2 homology domain 3 |
| Bid | BH3-only protein |
| BITC | benzyl isothiocyanate |
| CDK9 | cyclin-dependent kinase 9 |
| c-FLIP | cellular (FADD-like IL-1β-converting enzyme)-inhibitory protein |
| cIAP | cellular IAP |
| c-Myc | avian myelocytomatosis virus oncogene cellular homolog |
| DcR | decoy receptor |
| CPT | circularly permuted TRAIL |
| DD | death domain |
| DDR | DNA damage response |
| DGCR8 | DiGeorge critical region8 |
| DR | death receptor |
| ER | endoplasmic reticulum |
| ERK | extracellular signal-regulated kinase |
| FADD | Fas-associated death domain |
| Fc | Fragment crystallizable |
| Flag | DYKDDDDK |
| FLICE | FADD-like IL-1β-converting enzyme |
| FOLFIRINOX | FOL-folinic acid, F-5-fluorouracil (5-FU), IRIN-irinotecan, OX-oxaliplatin |
| GALNT14 | N-acetylgalactosaminyltransferase-14 |
| GTP | guanosine-5′-triphosphate |
| HcAbs | heavy-chain-only antibodies |
| HDAC | histone deacetylase |
| HMGA2 | high-mobility group AT-hook 2 |
| IAP | inhibitor of apoptosis protein |
| IGF-R | insulin-like growth factor receptor |
| IgG | immunoglobulin |
| IGFR | insulin-like growth factor receptor |
| IKK | inhibitor of κB kinase |
| IMS | intermembrane space |
| IκB | inhibitor of κB |
| IZ | isoleucine zipper |
| JNK | c-JUN N-terminal kinase |
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
| LUBAC | linear ubiquitin chain assembly complex |
| LZ | leucine zipper |
| mAb | monoclonal antibody |
| MAPK | mitogen-activated protein kinase |
| Mcl-1 | myeloid leukemia cell differentiation protein |
| memTRAIL | membrane-bound TRAIL |
| miRNA | micro RNA |
| MOM | mitochondrial outer membrane |
| MOMP | mitochondrial outer membrane permeabilization |
| MTD | membrane-proximal domain |
| nab | nanoparticle albumin-bound |
| NEMO | NF-κB essential modifier |
| NF-κB | nuclear factor kappa light chain enhancer of activated B cells |
| N-glyc | N-glycosylation |
| NIK | NF-κB-inducing kinase |
| nTRAIL | nuclear TRAIL |
| O-glyc | O-glycosylation |
| OPG | osteoprotegerin |
| p38 MAPK | p38 mitogen-activated protein kinase |
| PARP | poly-ADP ribose polymerase |
| PCD | programmed cell death |
| PDAC | pancreatic ductal adenocarcinoma |
| Rac1 | Ras-related C3 botulinum toxin substrate 1 |
| RANKL | receptor activator of nuclear factor κB ligand |
| Ras | Rat sarcoma |
| rhTRAIL | recombinant human TRAIL |
| RIPK | receptor-interacting serine/threonine protein kinase 1 |
| scTRAIL-RBD | single-chain-TRAIL-receptor-binding domain |
| Smac/DIABLO | second mitochondrial activator of caspases/direct inhibitor of apoptosis-binding protein with low pI |
| SR | superfamily |
| SRC | Rous sarcoma oncogene cellular homolog |
| STAT | signal transducer and activator of transcription |
| sTRAIL | soluble TRAIL |
| TNF | tumor necrosis factor |
| TAPE | threonine, alanine, proline, glutamine |
| TRAIL | TNF-related apoptosis-inducing ligand |
| TRAIL-R | Trail receptor |
| Ub | ubiquitin |
| VHH | heavy chain domain |
| XIAP | X-linked inhibitor of apoptosis protein |